An inhaled steroid improves markers of airway inflammation in patients with mild asthma

European Respiratory Journal

Volumn 12, Issue 5, 1998, Pages 1084-1088

  Jatakanon, A ^a   Lim, S ^a   Chung, K F ^a   Barnes, P J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Asthma; Budesonide; Eosinophil cationic protein; Eosinophils; Induced sputum; Nitric oxide

Indexed keywords

BUDESONIDE; EOSINOPHIL CATIONIC PROTEIN; NITRIC OXIDE; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRY POWDER; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SPUTUM ANALYSIS;

EID: 0031790204     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12051084     Document Type: Article

References (28)

1. Djukanovic R, Roche WR, Wilson JW, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142: 434-457.
2. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 1993; 148: S1-26.
3. British Thoracic Society. The British Guidelines on Asthma Management. Thorax 1997; 52: S1-S21.
4. Haahtela T, Jarvinen M, Kava T, et al. Comparison of a beta-2-agonist, terbutaline, with an inhaled corticosteroid. budesonide, in newly detected asthma. N Engl J Med 1991; 325: 388-392.
5. Haahtela T, Jarvinen M, Kava T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994; 331: 700-705.
6. Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47: 25-29.
7. Fahy JV. Liu J, Wong H, Boushey HA. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis 1993; 147: 1126-1131.
8. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153: 530-534.
9. Pizzichini L, Pizzichini MM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154: 308-317.
10. in't Veen JC, de Gouw HW, Smits HH, et al. Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. Eur Respir J 1996; 9: 2441-2447.
11. Gibson PG, Wong BJ, Hepperle MJ, et al. A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid. Clin Exp Allergy 1992; 22: 525-532.
12. Pin I, Freitag AP, O'Byrne PM, et al. Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. Am Rev Respir Dis 1992; 145: 1265-1269.
13. Claman DM, Boushey HA, Liu J, Wong H, Fahy JV. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects. J Allergy Clin Immunol 1994; 94: 861-869.
14. Keatings VM, Jatakanon A, Worsdell YM, Barnes PJ. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155: 542-548.
15. Alfaro C, Sharma OP, Navarro L, Glovsky MM. Inverse correlation of expiratory lung flows and sputum eosinophils in status asthmaticus. Ann Allergy 1989; 63: 251-254.
16. Virchow JC Jr, Holscher U, Virchow C Sr. Sputum ECP levels correlate with parameters of airflow obstruction. Am Rev Respir Dis 1992; 146: 604-606.
17. Kharitonov SA, Yates D, Robbins RA, Logan Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343: 133-135.
18. Kharitonov SA, O'Connor BJ, Evans DJ, Barnes PJ. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med 1995; 151: 1894-1899.
19. Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996; 153: 454-457.
20. 2-agonists on exhaled nitric oxide in asthmatic patients. Eur Respir J 1997; 10: 1483-1488.
21. Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998; 53: 91-95.
22. Chai H, Farr RS, Frochlich LA, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975; 56: 323-327.
23. Kharitonov SA, Chung KF, Evans R, O'Connor BJ, Barnes PJ. Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. Am J Respir Crit Can Med 1996; 153: 1773-1780.
24. nd Edn. London, Edward Arnold, 1994; pp.78-91.
25. Springall DR, Meng Q, Redington A, Howarth PH, Evans TJ, Polak JM. Inducible nitric oxide syntase in asthmatic airway epithelium is reduced by corticosteroid therapy. Am J Respir Crit Care Med 1995: 151: A833.
26. Kraan J, Koeter GH, van der Mark TW, et al. Dosage and time effects of inhaled budesonide on bronchial hyperreactivity. Am Rev Respir Dis 1988; 137: 44-48.
27. Barnes PJ. Effect of corticosteroids on airway hyperresponsiveness. Am Rev Respir Dis 1997; 141: S70-S76.
28. Konno S, Gonokami Y, Kurokawa M, et al. Cytokine concentrations in sputum of asthmatic patients, Int Arch Allergy Immunol 1996; 109: 73-78.